Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-04-26

FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for FOSAMAX PLUS D (alendronate sodium and cholecalciferol) submitted by Organon LLC. This approval supports changes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosamax Plus D (Alendronate Sodium and Cholecalciferol)

Snippet

SUPPL AP for FOSAMAX PLUS D (ALENDRONATE SODIUM AND CHOLECALCIFEROL)